Psy-World
This site is sponsored by an unrestricted educational grant from Pierre Fabre Médicament

Neuropsychiatric Disease and Treatment

Neuropsychiatic Disease and Treatment is the official journal of the International Neuropsychiatric Association. It provides a unique forum where neurology meets psychiatry. It encourages both experimental and clinical research. It has a distinguished Editorial Board, and peer review standards are high. The Commentary and Expert opinion sections of the journal allow people to express sometimes controversial views which are not always associated with the more traditional review and original research articles.

Roger M Pinder - Founding Editor

Neuropsychiatric Disease and Treatment

2009 Volume 5


All articles in volume 5

Selected recent papers

With the adoption of OPEN ACCESS the journal has abandoned the concept of monthly issues and publishes papers online as soon as they are available.

Psy-World.com will therefore highlight recent papers of particular interest to psychiatrists
and neuroscientists as soon as they appear on line

The full text of all papers are now freely available online through OPEN ACCESS.
Click on the titles to access the abstracts and then the full text.


Clinical features of adolescents with deliberate self-harm: A case control study in Lisbon, Portugal
Diogo F Guerreiro, Ema L Neves, Rita Navarro, et al

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
Robert H Howland

Late- versus early-onset geriatric depression in a memory research center
Carol Dillon, Ricardo F Allegri, Cecilia M Serrano, et al

Brain-derived neurotrophic factor: role in depression and suicide
Yogesh Dwivedi

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
Alla Avedisova, Vladimir Borodin, Ksenia Zakharova, Artem Aldushin

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
Heidemarie Abrahamian, Peter Hofmann, Rudolf Prager, Hermann Toplak

Updated November 2009


Follow this link for further information on this journal, instructions to authors and more articles


Site conceived and produced by NeuroBiz Consulting & Communications
Copyright © Mike Briley & Chantal Moret, 2009